CONDENSED FINANCIAL INFORMATION - PARENT COMPANY ONLY, Cash Flows (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Cash flows from operating activities [Abstract]
Net income	$ 17,811	$ 29,060	$ 29,118
Adjustments to reconcile net income to net cash provided by operating activities [Abstract]
Investment securities losses (gains), net	144	247	(339)
Other, net	668	(330)	180
Net cash provided by operating activities	26,537	33,240	38,693
Cash flows from investing activities [Abstract]
Purchases of equity securities	(10,246)	(117,913)	(211,218)
Proceeds from sale of equity securities	127	33	0
Net cash provided by (used in) investing activities	59,465	(362,452)	(158,232)
Cash flows from financing activities [Abstract]
Cash dividends paid	(8,503)	(7,588)	(7,383)
Purchase of treasury stock	(265)	(1,279)	(1,374)
Sale of treasury stock to employee stock purchase plan	34	112	0
Net cash provided by (used in) financing activities	(59,395)	182,590	223,665
Net increase (decrease) in cash and cash equivalents	26,607	(146,622)	104,126
Cash and Cash Equivalents at Beginning of Year	26,211	172,833	68,707
Cash and Cash Equivalents at End of Year	52,818	26,211	172,833
Parent Company [Member]
Cash flows from operating activities [Abstract]
Net income	17,811	29,060	29,118
Adjustments to reconcile net income to net cash provided by operating activities [Abstract]
Equity in undistributed earnings of subsidiaries	(7,804)	(22,135)	(20,744)
Investment securities losses (gains), net	209	219	(284)
Other, net	(206)	240	543
Net cash provided by operating activities	10,010	7,384	8,633
Cash flows from investing activities [Abstract]
Purchases of equity securities	0	(218)	0
Proceeds from sale of equity securities	127	33	0
Investment in subsidiaries	(15,000)	0	0
Acquisition of HVB	(10,780)	0	0
Net cash provided by (used in) investing activities	(25,653)	(185)	0
Cash flows from financing activities [Abstract]
Cash dividends paid	(8,503)	(7,588)	(7,383)
Issuance of subordinated debt	0	0	9,869
Issuance of short-term debt	12,572	0	0
Purchase of treasury stock	(265)	(1,279)	(1,374)
Sale of treasury stock to employee stock purchase plan	34	112	0
Purchase of restricted stock	0	0	0
Net cash provided by (used in) financing activities	3,838	(8,755)	1,112
Net increase (decrease) in cash and cash equivalents	(11,805)	(1,556)	9,745
Cash and Cash Equivalents at Beginning of Year	13,490	15,046	5,301
Cash and Cash Equivalents at End of Year	$ 1,685	$ 13,490	$ 15,046